this hypothesis was evaluated by measuring the serum levels of ca 125 in 81 patients with ovarian cancer ( 25 with nonactive and 56 with active disease ) , in 105 patients of both sexes with nonovarian tumors , and in 171 healthy controls of both sexes .
C0012634
disease
C0027651
tumors